Journal of Ginseng Research

  • 제27권3호
  • /
  • Pages.98-102
  • /
  • 2003
  • /
  • 1226-8453(pISSN)
  • /
  • 2093-4947(eISSN)
고려인삼학회 (The Korean Society of Ginseng)
권호 표지
DOI QR코드

DOI QR Code

Clinical Usefulness of Korean Red Ginseng in Postmenopausal Women with Severe Climacteric Disturbance

  • Kikuchi, Yoshihiro (Department of Obstetrics and Gynecology, National Defense Medical College) ;
  • Tode, Takehiko (Department of Obstetrics and Gynecology, National Defense Medical College) ;
  • Hirata, Junko (Department of Obstetrics and Gynecology, National Defense Medical College) ;
  • Nakataand, Hideyui (Department of Obstetrics and Gynecology, National Defense Medical College) ;
  • Kita, Tsunekazu (Department of Obstetrics and Gynecology, National Defense Medical College)
  • 발행 : 2003.09.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The aim of this study is to evaluate clinical usefulness of Korean red ginseng (RG) on various postmenopausal syndromes. Total plasminogen inhibitor-l (tPAI-l) in peripheral blood from 9 postmenopausal women with climacteric syndromes (CS) was measured before and 3 months after treatment with daily oral administration of 6 g RG and that from 8 postmenopausal women without any CS was also measured as healthy controls. Blood samples were collected in the early morning on the bed-rest. Psychological conditions of postmenopausal women with CS were measured before and 3 months after treatment with RG using simplified menopausal index (SMI). In addition, OKETSU (blood stagnation) syndrome scores and KI deficiency (generalized energy stagnation) scores proposed by Terasawa et al., were recorded before and 3 months after treatment with RG in postmenopausal women with CS and in healthy postmenopausal women. OKETSU syndrome scores and tPAI-l levels in postmenopausal patients with CS were significantly (P<0.001 and P<0.01) higher than those in healthy postmenopausal women without CS. Similarly, SMI scores and KI deficiency scores in postmenopausal patients with CS were about three-fold higher than those without any CS. When RG was administered for 3 months, KI deficiency scores and OKETSU scores as well as SMI scores declined around the levels of healthy postmenopausal women. Although tPAI-1 levels significantly (P<0.05) decreased after treatment with RG, those did not reach the levels of healthy postmenopausal women. Clinical usefulness of administration of RG to postmenopausal women with CS was confirmed from evaluation not only by modem medicine but also by traditional KAMPO medicine.

키워드

참고문헌

  1. Matthews, K. A., Wing, R. R. Kuller, L. H. Meilahn, E. N. Kelsey, S. F. Costello, E. J. et al. : Influence of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. J. Consult. Clin. Psychol. 58, 345-351 (1990) https://doi.org/10.1037/0022-006X.58.3.345
  2. Eisenberg, D. M., Davis, R. B. Ettner,S. L. et aI. : Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280, 1569-1575 (1998) https://doi.org/10.1001/jama.280.18.1569
  3. Eisenberg, D. M., Kessler, R. C. Foster, C. Norlock, F. E.' Valkins, D. R., and Delbanco, T. L. : Unconventional medicine in the United States: Prevalence, costs, and patterns of use. N. Eng. J. Med. 32, 246 (1993) https://doi.org/10.1056/NEJM199301283280406
  4. Kessel, B. : Alternative to estrogen for menopausal women. Proc. Soc. Exp. BioI. Med. 217, 38-44 (1998) https://doi.org/10.3181/00379727-217-44203
  5. Greenspan, E. M. : Ginseng and vaginal bleeding. JAMA. 249, 2108 (1983) https://doi.org/10.1001/jama.249.15.2018b
  6. Ogita, S. : Clinical application of Korean red ginseng in gynecological diseases. Ginseng Rev. 6, 363-370 (1988)
  7. Nagata, K. and Okamoto, A. : The effects of red ginseng to human stress condition the first report. Ginseng Rev. 22, 25-28 (1996)
  8. Tode, T., Kikuchi, Y. Hirata, J. Kita, T. Nakata, H. and Nagata, I. : Effects of Korean red ginseng on the neuroim-munoendocrine functions in ovarian cancer patients with post-operative chemotherapy or in patients with severe cli-macteric disturbance; Evaluation of antistress actions by Koran red ginseng. Ginseng Rev. 25, 101-106 (1998)
  9. Tode, T., Kikuchi, Y. Hirata, J. Kita, T. and Nagata, I. : Effects of red ginseng on the neuroimmunoendocrine func-tions in patients after surgery of ovarian carcinoma or with perimenopausal psychosomatic complaints. Ginseng Rev. 22, 110-114 (1996)
  10. Tode, T., Kikuchi, Y. Hirata, J. Kita, T. Nakata, H. and Nagata, I. : Effect of Korean red ginseng on psychological functions in patients with severe climacteric syndromes. Int. J. Gynecol. Obstet. 67, 169-174 (1999) https://doi.org/10.1016/S0020-7292(99)00168-X
  11. Terasawa, K., Toriizuka, K. Tosa, H. Ueno, M. Hayashi, T. and Shimizu, M. : Rheological studies on 'Oketsu' syn-dromes I. The blood viscosity and diagnostic criteria. J. Med. Pharm. Soc. WAKANYAKU. 3, 98-104 (1986)
  12. Sogabe, M., Furusaki, F. Sorin, T. and Kohno, H. : Develop-ment of new reagent for measuring total amountof plasmino-gen activator inhibitor-1 in plasma using latex photometric immuno assay system. Igaku no Ayumi. 173, 997-998 (1995)
  13. Kupperman, H. S., Blatt,M. H. G. Wiesboden, H. and Filler, W. : Comparative clinical evaluation of estrogen prepara-tions by the menopausal and amenorrhoeal indices. J. Clin. Endocrinol. 13, 88-95 (1953) https://doi.org/10.1210/jcem-13-6-688
  14. Vassalli, J. D., Sappino, A-P. and Belin, D. : The plasmino-gen activator/plasmin system. J. Clin. Invest. 88, 1067-72 (1991) https://doi.org/10.1172/JCI115405
  15. Wiman, B. and Hamsten, A. : Impaired fibrinolysis and risk of thromboembolism. Prog. Cardiovasc. Dis. 34, 179-192 (1991) https://doi.org/10.1016/0033-0620(91)90012-B
  16. Schneiderman, J., Sawdy, M. S. Keeton, M. R. Bordin, G. M. Bernstein, E. F. Dilley, R. B. and Loskutoff, J.: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. USA. 89, 6998-7002 (1992) https://doi.org/10.1073/pnas.89.15.6998
  17. Juhan-Vague, I. and Alessi, M. C. : Plarninogen activator inhib-itor 1 and atherothrombosis. Thrombo. Haemost. 70, 138-43 (1993)